Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,626.70
(
0.35%
)
News Focus
News Focus
Post# of 448124
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

alternatepatel

Send PM Follow Ignore
Followers 12
Posts 1019
Boards Moderated 0
Alias Born 03/24/2013

alternatepatel

Re: zumantu post# 5363

Monday, 04/29/2013 12:07:03 PM

Monday, April 29, 2013 12:07:03 PM

Post# of 448124
Re:Zumantu

the figures at the end of the patent application you posted show lipid peroxide lowering effect of various statins with EPA.

However, combo data to be published in this quarter are regarding PharmacoKinetic studies, Fixed Dose Combination (FDC) of Vascepa+Statin combo pill vs. Vascepa and statin (two pills taken together), so we can't really figure out which is THE ONE

i personally believe its Rosuvastatin (crestor)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News